Bio Protocol vs Radiant Capital — how do they compare? Bio Protocol trades at Rp439.21 (market cap Rp1T, Rp164,77M 24h volume), while Radiant Capital trades at Rp55.8 (market cap Rp128,13M, Rp581,09M 24h volume). The key difference: Bio Protocol is far larger — about 7804.6× Radiant Capital's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 1,4B / 1,5B RDNT (93%) for Radiant Capital. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Radiant Capital for 20 Days on average.
| BIO | RDNT | |
|---|---|---|
Market Cap | Rp1T | Rp128,13M |
Volume (24h) | Rp164,77M | Rp581,09M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 1,4B / 1,5B RDNT (93%) |
Typical Hold Time | 18 Days | 20 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Radiant Capital is a DeFi protocol that tackles capital fragmentation by creating a unified omnichain money market. It enables users to easily deposit and borrow assets across multiple blockchains, improving efficiency and user experience in the DeFi ecosystem.
Read more on RDNT →